With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...

Those who rely on certain Medtronic MiniMed insulin pump models to administer insulin could be at risk, according to the U.S. Food and Drug Association. On June 27, the FDA issued a recall on 11 ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), has emerged as a significant advancement in diabetes technology over the last 50 years. Although commercial insulin ...

Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The global insulin pump market was valued at 6.10 billion in 2024 and is expected to reach US$ 25.40 billion by 2033, growing at a CAGR of 17.2% from 2025 to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA granted 510(k) clearance for a tubeless insulin ...

The US Food and Drug Administration (FDA) on Wednesday announced that Minnesota-based device manufacturer Medtronic is recalling certain insulin pumps that might not provide the correct insulin dosing ...

The U.S. Food and Drug Administration is warning patients who use a particular insulin pump system that unauthorized people could access it and change how much insulin a patient receives. The pump at ...

In diabetes management, insulin pumps represent transformative technological breakthroughs that provide individuals with a vital pathway to improved health and enhanced quality of life. These portable ...

Using an insulin pump is an act of profound trust. Diabetic patients wear their insulin pumps at virtually all hours, relying on the medical machinery to administer doses of a potentially lethal ...